🧬 Why 40% of Venture Funds Failed Last Year (And How to Avoid It) | Krish Ramadurai (2/4)

The Biotech Startups Podcast

Content provided by Jon Chee. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jon Chee or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

8d ago 31:24

MP3•Episode home

🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.

As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.

"I was not like, 'Well, this partner helped me on it, and then we shared the deal.' I was like, 'I think I'm good at this because I basically did the output of an entire firm by myself, like, the first two years.'"

In this episode of The Biotech Startups Podcast, host Jon Chee continues his conversation with Krish Ramadurai, exploring his unconventional journey from Harvard academia to becoming a venture capital partner in record time. Krish shares how he applied his research training to venture capital, identifying a new category of compute-driven biotech companies before "TechBio" even existed, and executing twelve investments during his first year as an analyst—all while the COVID-19 pandemic sent markets into free fall.

Krish reveals the critical importance of "shot-calling" in venture capital, explaining why many talented associates and principals get stuck in their careers by not claiming ownership of their wins. He describes compressing his MBA into sixteen months at Washington University while working two full-time positions, his rapid ascent from analyst to partner by consistently performing above his role, and the uncomfortable but necessary transition from technical expert to fundraiser when dealing with limited partners. Throughout the conversation, Krish emphasizes breaking traditional rules when conviction demands it, treating every investment like an evidence-based academic experiment, and understanding that in venture capital, you're only as good as your last deal.

Key topics covered:

Evidence-Based Venture Capital: Applying academic research methodology to investment diligence and thesis development during COVID-19 market uncertainty
Identifying TechBio Before It Existed: Market mapping compute-driven biotech companies and building a comprehensive thesis workbook that led to investments in Insilico Medicine, Red AI, and others
The Art of Shot-Calling: Why claiming ownership of your wins is critical for advancing from analyst to partner, and how many VCs get stuck by sharing credit
Accelerated Career Progression: Navigating the venture capital hierarchy by doing work above your pay grade and forcing conversations about promotion through demonstrated results
The LP Fundraising Reality: Transitioning from technical diligence to selling yourself as a jockey to institutional investors, understanding emerging versus established fund dynamics

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

Subscribe to the Podcast:

Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994

Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4

Youtube: https://www.youtube.com/@thebiotechstartupspodcast

Website: https://www.thebiotechstartupspodcast.com/

Find our guest, Krish Ramadurai, at these links:

https://www.linkedin.com/in/krishramadurai/

https://www.aixventures.com/

Find our host, Jon Chee, at these links:

LinkedIn: https://www.linkedin.com/in/jonchee

Learn more about Excedr:

LinkedIn: https://www.linkedin.com/company/excedr/

Website: https://www.excedr.com

Intro & Outro Songs Created by OkKyojin, Owned by Excedr:

Website: https://flow.page/kyojin

Resources & Articles:

Due Diligence Best Practices in Venture Capital: https://www.wallstreetprep.com/knowledge/venture-capital-diligence/

Market Mapping for Venture Investors: https://www.growthmentor.com/glossary/market-mapping/

Companies, Universities, & People mentioned:

Harvard University (Belfer Center, Taubman Center): https://www.harvard.edu/

MIT: https://www.mit.edu/

Washington University in St. Louis (WashU): https://wustl.edu/

Timestamps:

00:00 Intro

02:22 Evidence-Based Approach from Academic Research to Venture

05:32 First Day at Harmonics and COVID's Impact

06:39 MBA While Working Full-Time at MIT

11:18 Market Mapping and Building a Thesis

16:29 Shot-Calling and Career Advancement in Venture

19:35 Accelerating from Analyst to Principal

22:02 Transition to Partner and Ownership of Thesis

23:31 Fundraising from LPs During COVID

25:48 Understanding LP Landscape and Emerging Manager Dynamics

30:05 Outro

The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.

198 episodes

#Science #Biology #Business #Jon Chee #Biotech Startups #Biotech #Startups #Excedr #Life Sciences #Entrepreneur #Founders #Culture